Credit Suisse’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $854K | Sell |
32,517
-1,832
| -5% | -$52.2K | ﹤0.01% | 2358 |
|
|
2023
Q4 | $1.08M | Sell |
34,349
-131,816
| -79% | -$3.58M | ﹤0.01% | 2286 |
|
|
2023
Q3 | $4.66M | Sell |
166,165
-6,635
| -4% | -$228K | ﹤0.01% | 1314 |
|
|
2023
Q2 | $6.37M | Buy |
172,800
+5,172
| +3% | +$158K | 0.01% | 1176 |
|
|
2023
Q1 | $5.02M | Sell |
167,628
-12,724
| -7% | -$419K | 0.01% | 1314 |
|
|
2022
Q4 | $5.52M | Buy |
180,352
+36,082
| +25% | +$1.08M | 0.01% | 1241 |
|
|
2022
Q3 | $3.56M | Sell |
144,270
-769
| -0.5% | -$25.4K | ﹤0.01% | 1466 |
|
|
2022
Q2 | $4.64M | Sell |
145,039
-2,237
| -2% | -$82.3K | ﹤0.01% | 1327 |
|
|
2022
Q1 | $4.64M | Buy |
147,276
+370
| +0.3% | +$11.6K | ﹤0.01% | 1506 |
|
|
2021
Q4 | $4.93M | Sell |
146,906
-40,451
| -22% | -$1.26M | ﹤0.01% | 2032 |
|
|
2021
Q3 | $5.45M | Buy |
187,357
+28,837
| +18% | +$934K | ﹤0.01% | 1991 |
|
|
2021
Q2 | $5.47M | Sell |
158,520
-26,007
| -14% | -$861K | ﹤0.01% | 2007 |
|
|
2021
Q1 | $5.15M | Buy |
184,527
+7,617
| +4% | +$203K | ﹤0.01% | 2048 |
|
|
2020
Q4 | $4.39M | Buy |
176,910
+46,675
| +36% | +$1.11M | ﹤0.01% | 2194 |
|
|
2020
Q3 | $2.72M | Sell |
130,235
-100,857
| -44% | -$1.95M | ﹤0.01% | 2199 |
|
|
2020
Q2 | $3.55M | Sell |
231,092
-5,917
| -2% | -$74.8K | ﹤0.01% | 1938 |
|
|
2020
Q1 | $2.1M | Buy |
237,009
+87,610
| +59% | +$1.26M | ﹤0.01% | 2103 |
|
|
2019
Q4 | $2.7M | Sell |
149,399
-85,508
| -36% | -$1.42M | ﹤0.01% | 2372 |
|
|
2019
Q3 | $3.51M | Sell |
234,907
-2,039,354
| -90% | -$33.2M | ﹤0.01% | 2043 |
|
|
2019
Q2 | $54.6M | Buy |
2,274,261
+2,001,660
| +734% | +$59M | 0.05% | 405 |
|
|
2019
Q1 | $10.1M | Sell |
272,601
-11,944
| -4% | -$435K | 0.01% | 1235 |
|
|
2018
Q4 | $8.03M | Buy |
284,545
+80,855
| +40% | +$2.56M | 0.01% | 1278 |
|
|
2018
Q3 | $8.04M | Buy |
203,690
+14,675
| +8% | +$642K | 0.01% | 1388 |
|
|
2018
Q2 | $8.38M | Buy |
189,015
+8,476
| +5% | +$422K | 0.01% | 1342 |
|
|
2018
Q1 | $8.79M | Sell |
180,539
-52,317
| -22% | -$2.62M | 0.01% | 1319 |
|
|
2017
Q4 | $11.7M | Buy |
232,856
+13,354
| +6% | +$699K | 0.01% | 1172 |
|
|
2017
Q3 | $11.1M | Sell |
219,502
-47,572
| -18% | -$2.24M | 0.01% | 1188 |
|
|
2017
Q2 | $10.1M | Buy |
267,074
+83,577
| +46% | +$3.3M | 0.01% | 1199 |
|
|
2017
Q1 | $7.07M | Sell |
183,497
-57,239
| -24% | -$1.72M | 0.01% | 1408 |
|
|
2016
Q4 | $5.32M | Buy |
240,736
+76,497
| +47% | +$1.57M | 0.01% | 1602 |
|
|
2016
Q3 | $2.63M | Sell |
164,239
-9,860
| -6% | -$113K | ﹤0.01% | 2177 |
|
|
2016
Q2 | $1.43M | Sell |
174,099
-13,121
| -7% | -$117K | ﹤0.01% | 2613 |
|
|
2016
Q1 | $1.31M | Buy |
187,220
+418
| +0.2% | +$2.1K | ﹤0.01% | 2525 |
|
|
2015
Q4 | $1M | Sell |
186,802
-10,953
| -6% | -$70K | ﹤0.01% | 2811 |
|
|
2015
Q3 | $1.28M | Buy |
+197,755
| New | +$2.07M | ﹤0.01% | 2601 |
|
Other funds holding CC
VNIM
Credit Suisse's CC Position: Q1 2024 in Review
Credit Suisse reduced its Chemours (CC) stake by 5.3% in Q1 2024, selling an estimated $52.2K and leaving 32,517 shares worth $854K. The position accounts for ﹤0.01% of the portfolio, ranked #2358.
Credit Suisse first reported a position in CC in Q3 2015 and has held it in 35 quarters since. The position peaked at $54.6M in Q2 2019. 443 funds tracked by Wall St. Rank hold CC as of Q1 2024.
- Credit Suisse held 32,517 shares of Chemours worth $854K as of Q1 2024.
- Credit Suisse sold 1,832 Chemours shares in Q1 2024, an estimated $52.2K.
- Chemours made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2358 holding.
- Credit Suisse first reported a position in Chemours in Q3 2015 and has held it in 35 quarters since.
- Credit Suisse's Chemours position peaked at $54.6M in Q2 2019.
- 443 funds tracked by Wall St. Rank held Chemours as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.